Global Colloids (Blood Plasma) Market Research Report, Competitive, Technology and Forecast Analysis 2025-2032

Market Overview

According to DIResearch's in-depth investigation and research, the global Colloids (Blood Plasma) market size will reach Million USD in 2025 and is projected to reach Million USD by 2032, with a CAGR of % (2025-2032). Notably, the China Colloids (Blood Plasma) market has changed rapidly in the past few years. By 2025, China's market size is expected to be Million USD, representing approximately % of the global market share.

Research Summary

Colloids in blood plasma refer to a class of substances that are suspended in the liquid component of blood, known as plasma. These substances are larger molecules, such as proteins, that do not readily dissolve in the fluid but remain dispersed as particles. The most significant colloids in blood plasma are albumin and globulin, which play crucial roles in maintaining osmotic pressure, transporting hormones and nutrients, and regulating pH levels. Colloids contribute to the viscosity of blood and help to keep the balance of fluids within the blood vessels and surrounding tissues. They are essential for maintaining blood volume and overall cardiovascular function. Medical professionals may use colloid solutions, such as albumin or synthetic colloids, as intravenous fluids to support patients with low blood volume or shock. Understanding the behavior of colloids in blood plasma is essential for managing various medical conditions and ensuring proper fluid balance and tissue perfusion in the body.

The major global  manufacturers of Colloids (Blood Plasma) include CSL Behring, Baxter, Grifols, Octapharma, Kedrion, Shanghai Raas, CTBB, Hualan Bio, Rongsheng Pharmaceutical, Boya Rongsheng, B. Braun Medical, Fresenius Kabi, HOSPIRA, Axa parenterals, Fresenius Kabi(China), CR Double-Crane, Kelun Group, Shandong Qidu Pharmaceutical, Shandong Hualu Pharmaceutical, Minsheng Pharma, Kanglepharm, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.

This report studies the market size, price trends and future development prospects of Colloids (Blood Plasma). Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Colloids (Blood Plasma) market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.

The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Colloids (Blood Plasma) market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Colloids (Blood Plasma) industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.    

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of Colloids (Blood Plasma) Include:

CSL Behring

Baxter

Grifols

Octapharma

Kedrion

Shanghai Raas

CTBB

Hualan Bio

Rongsheng Pharmaceutical

Boya Rongsheng

B. Braun Medical

Fresenius Kabi

HOSPIRA

Axa parenterals

Fresenius Kabi(China)

CR Double-Crane

Kelun Group

Shandong Qidu Pharmaceutical

Shandong Hualu Pharmaceutical

Minsheng Pharma

Kanglepharm

Colloids (Blood Plasma) Product Segment Include:

Natural Type Colloids (Blood Plasma)

Synthetic Type Colloids (Blood Plasma)

Colloids (Blood Plasma) Product Application Include:

Extensive Burns

Massive Blood or Plasma Loss

Hypovolemic Shock

Others

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend

Chapter 2: Global Colloids (Blood Plasma) Industry PESTEL Analysis

Chapter 3: Global Colloids (Blood Plasma) Industry Porter's Five Forces Analysis

Chapter 4: Global Colloids (Blood Plasma) Major Regional Market Size (Sales, Revenue, Price) and Forecast Analysis

Chapter 5: Global Colloids (Blood Plasma) Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)

Chapter 6: Global Colloids (Blood Plasma) Sales, Revenue, Price and Forecast by Product Type

Chapter 7: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)

Chapter 8: Industrial Chain Analysis, Colloids (Blood Plasma) Different Application Market Analysis (Sales and Revenue), Sales Channel Analysis

Chapter 9: Research Findings and Conclusion

Chapter 10: Methodology and Data Sources Show more